Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
SEA-BCMA is a humanized antibody against BCMA, which may increase antibody-dependent cellular cytotoxicity and cellular phagocytosis and decrease proliferation, potentially leading to decreased tumor growth (Cancer Res July 1 2018 (78) (13 Supplement) 3833).
|DrugClasses||TNFRSF17 Antibody 14|
|CAS Registry Number||2115084-53-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|ACTR087 + SEA-BCMA||ACTR087 SEA-BCMA||0||1|
|Dexamethasone + SEA-BCMA||Dexamethasone SEA-BCMA||0||0|